![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/77b5aeed-848b-4194-9392-b15ab7aef2d1/gr1.gif)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/op/2022/op.2022.18.issue-3/op.21.00482/20220303/images/large/op.21.00482t1.jpeg)
Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice
![Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/57900c48-ea3e-4a94-83a6-3ca44db35abd/mfig005.jpg)
Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library
![PDF) External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | Anne Vincent-salomon - Academia.edu PDF) External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | Anne Vincent-salomon - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/86436036/mini_magick20220524-18718-tg1b1v.png?1653457246)
PDF) External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | Anne Vincent-salomon - Academia.edu
![Creation and Validation of a Novel Sex‐Specific Mortality Risk Score in LVAD Recipients | Journal of the American Heart Association Creation and Validation of a Novel Sex‐Specific Mortality Risk Score in LVAD Recipients | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/1d10e14c-9f13-4c46-948c-21b3e6c9e8af/jah36040-fig-0001.png)
Creation and Validation of a Novel Sex‐Specific Mortality Risk Score in LVAD Recipients | Journal of the American Heart Association
![The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-021-00366-x/MediaObjects/41523_2021_366_Fig1_HTML.png)
The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer
![JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report](https://www.mdpi.com/jpm/jpm-02-00071/article_deploy/html/images/jpm-02-00071-g001.png)
JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig1_HTML.png)
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
![Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d9703228-fc3a-4361-8574-cece79e56c05/gr1.jpg)
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology
![Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it? - ScienceDirect Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2049080121007433-gr5.jpg)
Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it? - ScienceDirect
![The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00276-y/MediaObjects/41523_2021_276_Fig1_HTML.png)